Absorption, Distribution, Metabolism, and Excretion of [(14)C]-Volixibat in Healthy Men: Phase 1 Open-Label Study

Lignende værker

• A randomised, double-blind, placebo-controlled phase 1 study of the safety, tolerability and pharmacodynamics of volixibat in overweight and obese but otherwise healthy adults: implications for treatment of non-alcoholic steatohepatitis
  af: Palmer, Melissa, et al.
  Udgivet: (2018)
• Absorption, distribution, metabolism, and excretion of [(14)C]-labeled naloxegol in healthy subjects
  af: Bui, Khanh, et al.
  Udgivet: (2015)
• Absorption, metabolism, excretion, and safety of [(14)C]almonertinib in healthy Chinese subjects
  af: Zhou, Chen, et al.
  Udgivet: (2021)
• Absorption, distribution, metabolism and excretion of molidustat in healthy participants
  af: Lentini, Silvia, et al.
  Udgivet: (2020)
• Absorption, distribution, metabolism, and excretion of [(14)C]‐dasotraline in humans
  af: Chen, Yu‐Luan, et al.
  Udgivet: (2016)